|
Volumn 55, Issue 2, 2002, Pages 169-173
|
A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: Effect of selective dopamine receptor agonist fenoldopam
|
Author keywords
Angioplasty; Chronic renal insufficiency; Contrast nephropathy
|
Indexed keywords
CONTRAST MEDIUM;
DOPAMINE 1 RECEPTOR STIMULATING AGENT;
FENOLDOPAM;
ADULT;
AGED;
ARTICLE;
CHRONIC KIDNEY FAILURE;
CLINICAL PROTOCOL;
CONTRAST ENHANCEMENT;
DIABETES MELLITUS;
DIALYSIS;
DRUG EFFECT;
DRUG SCREENING;
FEMALE;
HUMAN;
INCIDENCE;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
MORTALITY;
TRANSLUMINAL CORONARY ANGIOPLASTY;
AGED;
AGED, 80 AND OVER;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CONTRAST MEDIA;
CREATININE;
DOPAMINE AGONISTS;
FEMALE;
FENOLDOPAM;
HEART RATE;
HUMANS;
INCIDENCE;
KIDNEY DISEASES;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
NEW YORK;
TREATMENT OUTCOME;
|
EID: 0036161031
PISSN: 15221946
EISSN: None
Source Type: Journal
DOI: 10.1002/ccd.10038 Document Type: Article |
Times cited : (79)
|
References (20)
|